ArticleJournal of experimental & clinical cancer research : CR2019

Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma.

Yitian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.